 |  |
| ABX | ||
| 1,019.143 | ||
| 6.1410 | 0.0061% | |
| BISNIS-27 | ||
| 539.781 | ||
| -2.7680 | -0.0051% | |
| DBX | ||
| 1,966.414 | ||
| -2.7600 | -0.0014% | |
| ECONOMIC30 | ||
| 123.860 | ||
| -1.5040 | -0.0120% | |
| ESGQKEHATI | ||
| 129.543 | ||
| -0.7470 | -0.0057% | |
| ESGSKEHATI | ||
| 129.189 | ||
| -0.8210 | -0.0063% | |
| I-GRADE | ||
| 211.754 | ||
| -1.1160 | -0.0052% | |
| AUDRP | ||
| 10,368.700 | ||
| 50.2000 | 0.4865% | |
| EURRP | ||
| 16,756.100 | ||
| 33.2000 | 0.1985% | |
| JPYRP | ||
| 103.029 | ||
| 0.9960 | 0.9762% | |
| SINRP | ||
| 11,854.900 | ||
| 45.5000 | 0.3853% | |
| USDRP | ||
| 15,920.000 | ||
| 60.0000 | 0.3783% | |
Sejumlah lembaga asal Indonesia bekerja sama dengan perusahaan farmasi luar negeri dalam mengembangkan produksi vaksin COVID-19 di dalam negeri. Badan Pengawas Obat dan Makanan (BPOM) mencatat setidaknya terdapat lima pengembangan kandidat vaksin COVID-19 yang cukup menjanjikan.
